Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | HTR7 | P34969 | 2/20 | 0.52 |
| ▸ | HTR6 | P50406 | 1/20 | 0.52 |
| ▸ | HTR1A | P08908 | 5/20 | 0.48 |
| ▸ | HTR2A | P28223 | 4/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oleic Acid SCHEMBL17200212 | 1.00 | L3MBTL1 (0.60) | L3MBTL1HTR7HTR6HTR1AHTR2A | |
| SCHEMBL2296651 | 0.85 | L3MBTL1 (0.73) | L3MBTL1HTR7HTR6HTR1AHTR2A | |
| Hydrochloric Acid SCHEMBL2297385 | 0.85 | L3MBTL1 (0.72) | L3MBTL1HTR7HTR6HTR1AHTR2A | |
| SCHEMBL11159815 | 0.82 | L3MBTL1 (0.70) | L3MBTL1HTR7HTR6HTR1AHTR2A | |
| SCHEMBL682820 | 0.79 | L3MBTL1 (0.73) | L3MBTL1HTR7HTR6HTR1AHTR2A | |
| SCHEMBL10722927 | 0.77 | LMNA (0.58) | L3MBTL1HTR7HTR6HTR1AHTR2A | |
| SCHEMBL4461504 | 0.75 | L3MBTL1 (0.58) | L3MBTL1HTR7HTR1AHTR2A | |
| SCHEMBL17200213 | 0.75 | HTR1A (0.45) | HTR7HTR1AHTR2A | |
| Oleic Acid SCHEMBL23093936 | 0.75 | ADORA2B (0.56) | ALOX15 | |
| SCHEMBL2626922 | 0.74 | HTR7 (0.63) | L3MBTL1HTR7HTR6HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015161510-A1 | SAA DERIVATIVE COMPOUND RESTORES ENOS AND INHIBITS OXIDATIVE STRESS-INDUCED DISEASES IN HYPOXIA | JANSFAT BIOTECHNOLOGY CO., LTD. (CN) | 2015-10-29 | — | — | WO | disclosed |
| US-20150306107-A1 | SAA Derivative Compound Restores eNOS And Inhibits Oxidative Stress-Induced A Diseases In Hypoxia | JANSFAT BIOTECHNOLOGY CO., LTD. (TW) | 2015-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150306107-A1 | SAA Derivative Compound Restores eNOS And Inhibits Oxidative Stress-Induced A Diseases In Hypoxia | SAAL1, HMOX1, HIF1AN | L3MBTL1 1613/4885HTR7 3988/4885HTR6 1856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.